Advanced Proteome Therapeutics Announces Dr. Benjamin Krantz to Join Company as CEO
mcleanap2021-09-09T12:54:42-04:00Advanced Proteome Therapeutics Corporation (“APC” or the “Company’) (TSXV: APC) (FSE: 0E8), is pleased to announce that Dr. Benjamin Krantz will be joining the Company’s US subsidiary Advanced Proteome Therapeutics Inc. (“APTI”) as CEO following the completion of his oncology fellowship at NYU Langone Health on July 1st, 2021. Bill Dickie will continue his role as interim CEO of APTI until then and remain a member of the board of directors after.